|
1
|
Harbeck N and Gnant M: Breast cancer.
Lancet. 389:1134–1150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gu G, Dustin D and Fuqua SA: Targeted
therapy for breast cancer and molecular mechanisms of resistance to
treatment. Curr Opin Pharmacol. 31:97–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Y, He Y, Han S and Liang Y:
Identification and functional inference for tumor-associated long
non-coding RNA. IEEE/ACM Trans Comput Biol Bioinform. 16:1288–1301.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Munakata K, Uemura M, Takemasa I, Ozaki M,
Konno M, Nishimura J, Hata T, Mizushima T, Haraguchi N, Noura S, et
al: SCGB2A1 is a novel prognostic marker for colorectal cancer
associated with chemoresistance and radioresistance. Int J Oncol.
44:1521–1528. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wong RL, Wang Q, Trevino LS, Bosland MC,
Chen J, Medvedovic M, Prins GS, Kannan K, Ho SM and Walker CL:
Identification of secretaglobin Scgb2a1 as a target for
developmental reprogramming by BPA in the rat prostate.
Epigenetics. 10:127–134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bellone S, Tassi R, Betti M, English D,
Cocco E, Gasparrini S, Bortolomai I, Black JD, Todeschini P, Romani
C, et al: Mammaglobin B (SCGB2A1) is a novel tumour antigen highly
differentially expressed in all major histological types of ovarian
cancer: Implications for ovarian cancer immunotherapy. Br J Cancer.
109:462–471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Becker RM, Darrow C, Zimonjic DB, Popescu
NC, Watson MA and Fleming TP: Identification of mammaglobin B, a
novel member of the uteroglobin gene family. Genomics. 54:70–78.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu X, Wang N, Long XB, You XJ, Cui YH and
Liu Z: The cytokine-driven regulation of secretoglobins in normal
human upper airway and their expression, particularly that of
uteroglobin-related protein 1, in chronic rhinosinusitis. Respir
Res. 12:282011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lacroix M: Significance, detection and
markers of disseminated breast cancer cells. Endocr Relat Cancer.
13:1033–1067. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zubor P, Hatok J, Moricova P, Kajo K,
Kapustova I, Mendelova A, Racay P and Danko J: Gene expression
abnormalities in histologically normal breast epithelium from
patients with luminal type of breast cancer. Mol Biol Rep.
42:977–988. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Claerhout S, Lim JY, Choi W, Park YY, Kim
K, Kim SB, Lee JS, Mills GB and Cho JY: Gene expression signature
analysis identifies vorinostat as a candidate therapy for gastric
cancer. PLoS One. 6:e246622011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Li Z, Zheng W, Li X, Wang Z, Cui Y
and Jiang X: LncRNA-ATB: An indispensable cancer-related long
noncoding RNA. Cell Prolif. 50:2017. View Article : Google Scholar
|
|
13
|
Yan B, Yao J, Liu JY, Li XM, Wang XQ, Li
YJ, Tao ZF, Song YC, Chen Q and Jiang Q: lncRNA-MIAT regulates
microvascular dysfunction by functioning as a competing endogenous
RNA. Circ Res. 116:1143–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao Z, Li H, Du B, Cui K, Xing Y, Zhao X
and Zai S: LncRNA DANCR promotes migration and invasion through
suppression of lncRNA-LET in gastric cancer cells. Biosci Rep.
37:BSR201710702017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J, Geng Z, Weng J, Shen L, Li M, Cai
X, Sun C and Chu M: Microarray analysis reveals a potential role of
LncRNAs expression in cardiac cell proliferation. BMC Dev Biol.
16:412016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan Q and Liu B: Identification of a
RNA-Seq based 8-long non-coding RNA signature predicting survival
in esophageal cancer. Med Sci Monit. 22:5163–5172. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Zhang G, Zhang H, Karin M, Bai H
and Cai D: Hypothalamic IKKbeta/NF-kappaB and ER stress link
overnutrition to energy imbalance and obesity. Cell. 135:61–73.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Turco MC, Romano MF, Petrella A, Bisogni
R, Tassone P and Venuta S: NF-kappaB/Rel-mediated regulation of
apoptosis in hematologic malignancies and normal hematopoietic
progenitors. Leukemia. 18:11–17. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rogers C, Fernandes-Alnemri T, Mayes L,
Alnemri D, Cingolani G and Alnemri ES: Cleavage of DFNA5 by
caspase-3 during apoptosis mediates progression to secondary
necrotic/pyroptotic cell death. Nat Commun. 8:141282017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou A, Scoggin S, Gaynor RB and Williams
NS: Identification of NF-kappa B-regulated genes induced by
TNFalpha utilizing expression profiling and RNA interference.
Oncogene. 22:2054–2064. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kato T, Khanh VC, Sato K, Takeuchi K,
Carolina E, Yamashita T, Sugaya H, Yoshioka T, Mishima H and Ohneda
O: Corrigendum to ‘SDF-1 improves wound healing ability of
glucocorticoid-treated adipose tissue-derived mesenchymal stem
cells’ [Biochem. Biophys. Res. Commun. 493/2 (2017) 1010–1017].
Biochem Biophys Res Commun. 497:464–465. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Park JH, Seo YH, Jang JH, Jeong CH, Lee S
and Park B: Asiatic acid attenuates methamphetamine-induced
neuroinflammation and neurotoxicity through blocking of
NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway. J
Neuroinflammation. 14:2402017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan J, Xiang J, Lin Y, Ma J, Zhang J,
Zhang H, Sun J, Danial NN, Liu J and Lin A: Inactivation of BAD by
IKK inhibits TNFα-induced apoptosis independently of NF-βB
activation. Cell. 152:304–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taniguchi F, Uegaki T, Nakamura K, Mon KY
and Harada T, Ohbayashi T and Harada T: Inhibition of IAP
(inhibitor of apoptosis) proteins represses inflammatory status via
nuclear factor-kappa B pathway in murine endometriosis lesions. Am
J Reprod Immunol. 79:2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Y, Decker KF, Zheng D, Matkovich SJ,
Jia L and Dorn GW 2nd: A nucleus-targeted alternately spliced
Nix/Bnip3L protein isoform modifies nuclear factor KB
(NFKB)-mediated cardiac transcription. J Biol Chem.
288:15455–15465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oeckinghaus A and Ghosh S: The NF-kappaB
family of transcription factors and its regulation. Cold Spring
Harb Perspect Biol. 1:a0000342009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pires BR, Mencalha AL, Ferreira GM, de
Souza WF, Morgado-Díaz JA, Maia AM, Corrêa S and Abdelhay ES:
NF-kappaB is involved in the regulation of EMT genes in breast
cancer cells. PLoS One. 12:e01696222017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang Y, Wang Y, Kiani MF and Wang B:
Classification, treatment strategy, and associated drug resistance
in breast cancer. Clin Breast Cancer. 16:335–343. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Soudyab M, Iranpour M and Ghafouri-Fard S:
The role of long non-coding RNAs in breast cancer. Arch Iran Med.
19:508–517. 2016.PubMed/NCBI
|
|
33
|
Xue X, Yang YA, Zhang A, Fong KW, Kim J,
Song B, Li S, Zhao JC and Yu J: LncRNA HOTAIR enhances ER signaling
and confers tamoxifen resistance in breast cancer. Oncogene.
35:2746–2755. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang Q, Wang J, Wu X, Ma R, Zhang T, Jin
S, Han Z, Tan R, Peng J, Liu G, et al: LncRNA2 target: A database
for differentially expressed genes after lncRNA knockdown or
overexpression. Nucleic Acids Res. 43:D193–D196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Boon RA, Jae N, Holdt L and Dimmeler S:
Long noncoding RNAs: From clinical genetics to therapeutic targets?
J Am Coll Cardiol. 67:1214–1226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen KS, Lim JWC, Richards LJ and Bunt J:
The convergent roles of the nuclear factor I transcription factors
in development and cancer. Cancer Lett. 410:124–138. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun SC: The non-canonical NF-kappaB
pathway in immunity and inflammation. Nat Rev Immunol. 17:545–558.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huxford T, Huang DB, Malek S and Ghosh G:
The crystal structure of the IkappaBalpha/NF-kappaB complex reveals
mechanisms of NF-kappaB inactivation. Cell. 95:759–770. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Youle RJ and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pena-Blanco A and Garcia-Saez AJ: Bax, Bak
and beyond - mitochondrial performance in apoptosis. FEBS J.
285:416–431. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ashkenazi A, Fairbrother WJ, Leverson JD
and Souers AJ: From basic apoptosis discoveries to advanced
selective BCL-2 family inhibitors. Nat Rev Drug Discov. 16:273–284.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bierhoff H: Analysis of lncRNA-protein
interactions by RNA-protein pull-down assays and RNA
immunoprecipitation (RIP). Methods Mol Biol. 1686:241–250. 2018.
View Article : Google Scholar : PubMed/NCBI
|
